A AB BS S T TR RA AC CT T The aim of this re vi ew is to de fi ne the cell ba sed the rapy app li ca ti ons, to get her with re vi si on of up to da te li te ra tu re in pe rip he ral ar tery di se a ses, pre do mi nantly, the pos sib le mec hanisms of the the ra u pe tic ef fect re gar ding the ex pe ri men tal stu di es. Cli ni cal stu di es abo ut this is sue will be men ti o ned li mi tedly. The is su e tit les which must be ans we red by the an gi o ge ne sis stu di es which are tar ge ted by the cell ba sed the ra pi es will al so be men ti o ned thro ug ho ut this pa per. The term re ge ne ra ti ve me di ci ne re fers to the stra te gi es and met ho do lo gi es used in cu ring con di ti ons as op po sed to tre a ting them. Des pi te mo re than 10 ye ars of worl dwi de ac ti vity on adult stem cell deve lop men tal plas ti city (me ta mo i ro sis), cur rent re sults of fun da men tal re se arch are still in the emb ryo nic sta ge. Car di o vas cu lar di sor ders are the le a ding ca u ses of mor ta lity and mor bi dity in the de ve lo ped world. Cell-ba sed mo da li ti es ha ve re ce i ved con si de rab le sci en ti fic at ten ti on over the last de ca de for the ir po ten ti al use in this cli ni cal are na. The qu es ti on, whet her or not fu tu re im pro vements on cell-ba sed the ra pi es will pro vi de re mar kab le im pro ve ment in sur vi val and qu a lity of li fe for mil li ons of pa ti ents with car di o vas cu lar di sor ders still re ma ins un sol ved.
K Ke ey y W Wo or rd ds s: : Stem cell; pe rip he ral vas cu lar di se a se; an gi o ge ne sis; mo le cu lar mec ha nism Ö ÖZ ZE ET T Bu der le me nin ama cı, pe ri fer ar ter has ta lı ğı ile il gi li gün cel ya yın la rı in ce le ye rek, te ra pö tik et ki nin ola sı me ka niz ma la rı nın in ce len di ği araş tır ma lar ışı ğın da, hüc re ta ban lı te da vi uy gu la ma ları nı ta nım la mak tır. Bu ko nuy la il gi li kli nik ça lış ma lar dan kı sıt lı ola rak bah se di le cek tir. An ji o genez ko nu sun da ya pı lan ça lış ma lar ile in ce le nen ko nu baş lık la rı na da bu der le me için de yer ve ril mek te dir. Me tin içe ri sin de ona rım sal tıp te ri miy le kast edi len te da vi ye ri ne ta ma men iyi leş me yo lun da iz le nen tıb bi stra te ji ve me to do lo ji ler dir. Eriş kin kök hüc re le ri nin ge li şim sel plas ti si te si (me ta mo i ro sis) üze rin de ya pı lan ça lış ma lar 10 yı lı aş kın sü re dir de vam et mek te ol sa da, te mel bilim sel so nuç lar ha len em bri yo nik aşa ma da dır. Kar di yo vas kü ler has ta lık lar, ge liş miş ül ke ler de morta li te ve mor bi di te nin baş lı ca se be bi dir. Hüc re ta ban lı te da vi yak la şım la rı, geç ti ği miz on yıl için de kli nik alan da ki po tan si yel kul la nım alan la rı se be biy le yo ğun il gi gör mek te dir. İle ri ki yıl lar da hüc -re-ta ban lı te da vi yak la şım la rın da ki ge liş me le rin, kar di yo vas kü ler has ta lık lar dan et ki le nen mil yonlar ca in sa nın ya şam ka li te si ne ve ha yat ta ka lı mı na an lam lı bir fay da sağ la yıp sağ la ya ma ya ca ğı ha len be lir siz li ği ni ko ru mak ta dır.
A An na ah h t ta ar r K Ke e l li i m me e l le er r: : Kök hüc re; pe ri fe ral vas kü ler has ta lık; an ji o ge nez; mo le kü ler me ka niz ma D Da a m ma ar r C Ce er r D De er rg g 2 20 01 12 2; ;2 21 1( (2 2) ): :1 10 01 1-- 9 9 Günseli ÇUBUKÇUOĞLU DENİZ, Reza DATOURİ, ti on of the se cells vi a mag ne tic ac ti va ted cell sor ting prin cip le. They re por ted that the EPCs for med ca pil lary web for ma ti on on the 7th day. In 1-6 weeks the nuc le us-mar ked EPCs ap pe a red in the new ves sel for ma ti on si tes and al most all the mar ked cells we re in cor re la ti on with the ca pil lary ves sel walls. In the de ta i led im mu no his toc he mi cal study of the se cells, it was shown that the mar ked EPCs sett led in the isc he mic si te aro und the ves sel web of the new ves sel for ma ti on si te. This study is the inno va tor of the cell-ba sed the ra pi es.
Kal ka et al. 2 has an im por tant imp li ca ti on about pe rip he ral isc he mi a mo dels. In the ir ex pe rimen tal study, EPCs which are cul ti va ted by cel lu lar cul tu re en vi ron ment are used. In the ex peri men tal pe rip he ral ex tre mity isc he mi a mo del of the ath ymic rats the ef fi cacy of the hu man EPCs are com pa red with the con trol gro up. In the iso lati on of the EPCs, flu o res cen ce-ac ti va ted cell sor ting (FACS) met hod was used. Af ter the isc he mi a and cell ba sed the rapy pro cess, ob ser va ti ons we re ma de in dif fe rent pe ri ods. It was se en that in the cell imp lan ta ti on gro up au to am pu ta ti on ra te was lo we red by 50%, ca pil lary den sity ra te and re gi o nal ex tre mity blo od flow in cre a sed sig ni fi cantly in early pe ri ods. This study has an his to ri cal im portan ce by me ans of using the EPCs in pe rip he ral extre mity isc he mi a.
PO TEN TI AL MO LE CU LAR MEC HA NISMS IN AN GI O GE NIC PRO CESS
For de fi ning the stem cell be ha vi o ur and the ir diffe ran ti a ti on pro cess and en ligh te ning the po ten tial mo le cu lar mec ha nisms in the se pro ces ses, many in for ma ti ons are ad ded to the li te ra tu re. In de fining the cell cycle, "nic he " con cept is used recently. "Nic he " was de fi ned by Scho fi eld in 1978 as spe si fic ana to mic si tes which ma na ge the ro le of stem cells for tis su e re ne wing, pro tec ting and repa i ring. 3 Nic he is mostly in con tact with re la ted stem cells and con trols the pro li fe ra ti on whi le blocking the re duc ti on in stem cell num ber. Ho we ver, it pro vi des the stem cells' sur vi val wit ho ut any diffe ran ti a ti on. It was re por ted that the re is a fa i lu re bet we en stem cells and the nic he in tu mo ral de velop ment. 4 Nic he is one of the im por tant tar get si tes in stem cell the rapy and al so it is an im por tant com po nent for tis su e he mos ta sis.
Ac cor ding to the re cent da ta, stem cell nic hes are the most im por tant mec ha nisms in stem cell bio logy and be ha vi o ur re gu la ti on. 5 Hu mo ral, me tabo lic, physi cal, ne u ral and pa rac ri ne ef fects which af fect stem cell nic he con ti nu o usly af fect the nic he and can af fect the stem cell be ha vi o ur vi a the or gani sa ti on of the cells ne igh bo u ring it. 6 As a re sult of the sent mes sa ges over the nic he, so me cer ta in path ways and mo le cu lar mec ha nisms step in and then every stem cell symmet ri cally can pro du ce two si mi lar yo ung cells or two dif fe ran ti a ted cells (symmet ric cell di vi si on) or every stem cell tends to pro du ce a si mi lar yo ung cell and anot her dif fe renti a ted yo ung cell in the sa me di vi si on (asy mmet ric cell di vi si on). [6] [7] [8] The Notch re cep tor which is common in ver teb ra ted and non-ver teb ra ted ani mals inc lu des one path way trans mem bran pro te in and is mo du la ted by Del ta and Ser ra te li gands; it has very im por tant func ti ons in stem cell be ha vi o ur regu la ti on. 9 For examp le, the pro tec ti on of dif fe ranti a ti on in hi bi ti on and im ma tu re phe noty pe for he a mo po i e tic stem cells (HSCs) is pro vi ded by the Notch sig nal; dif fe ran ti a ti on sti mu la ti on is pro vided by the Wnt sig nal. 10 Un con trol led re gu la ti on in the Notch and Wnt sig nal mec ha nisms and their con ti nu o us path ways can ca u se disp las tic cell pro li fe ra ti on (can cer for ma ti on hypot he sis) or insuf fi ci ent re pa ir in ol der ages.
HSCs ha ve the abi lity to re new them sel ves and to gi ve ri se to all li ne a ges of the blo od; ho we ver, the sig nals that re gu la te HSC self-re ne wal still rema in unc le ar. Wnt sig nal ling path way has an impor tant ro le in this pro cess. Ove rex pres si on of ac ti va ted b-ca te nin ex pands the po ol of HSCs in long-term cul tu res by both phe noty pe and func tion. 11 The re se arc hers conc lu de that the Wnt signal ling path way is cri ti cal for nor mal HSC ho me os ta sis in vit ro and in vi vo, and pro vi des an in sight in to the po ten ti al mo le cu lar hi e rarchy of re gu la ti on of HSC de ve lop ment.
So me sig nal ways in the bo ne mar row (BM) nic he ha ve a ro le in the en dot he li al dif fe ren ti a tion. Os te ob lasts in the en dos te al nic he ex pres sing Jag ged-1 (Jag1) and N-cad he rin con tact and ma inta in HSCs by ac ti va ti on of Notch, and might further re gu la te HSC ac ti vity thro ugh N-cad he rin and β-ca te nin sig nal ling. The sig nal in te rac ti ons betwe en en dot he li al cell (EC) in vas cu lar nic he and HSCs is not well known. HSCs might be trans ported bet we en nic hes and sub jec ted to dif fe ren ti al regu la ti on in each nic he. ECs ex pres sing vas cu lar cell-ad he si on mo le cu le 1 (VCAM-1) al so as so ci a te clo sely with me ga kar yocy tes and the ir pro ge ni tors thro ugh very la te ac ti va ti on an ti gen 4 (VLA4) in res pon se to che mo tac tic fac tors, stro mal cell-de rived fac tor-1 (SDF1) and fib rob last growth fac tor-4 (FGF4), and pro vi de a nic he for me ga kar yocy te ma tu ra ti on and pla te let pro duc ti on. The im me di ate jux ta po si ti on of HSCs to ECs al so fa ci li ta tes their ra pid mo bi li za ti on and entry in to cir cu la ti on in res pon se to stress and, in the pre sen ce of me ga karyocy tes, re le a se of pla te lets di rectly in to the blo od. HSCs and ha e ma to po i e tic pro ge ni tor cells as well as me ga kar yocy tes pro du ce vas cu lar en dot he li al growth fac tor (VEGF) and ot her an gi o ge nic fac tors, which might act in a fe ed back lo op to sup port ECs in the BM and in the pe rip hery at si tes of nor mal and pat ho lo gic an gi o ge ne sis. 12 VEGF-A plays a regu la tor ro le for the ECs. Ho we ver which cell group wo uld be cho sen for vas cu lar web for ma ti on in an gi o ge nic pro cess is not de fi ned. In re cent stu dies it is ob ser ved that Del ta-li ke 4 (Dll4)-Notch 1 sig nal path way plays a ro le in the for ma ti on of vascu lar web. Hells trom et al. sho wed that in hi bi ti on of Notch sig nal ling using c-sec re ta se in hi bi tors, gene tic inac ti va ti on of one al le le of the en dot he li al Notch li gand Dll4 or en dot he li al-spe ci fic ge ne tic de le ti on of Notch1, all pro mo te in cre a sed num bers of tip cells. Con ver sely, ac ti va ti on of Notch by a solub le Jag1 pep ti de le ads to fe wer tip cells and vessel branc hes. Dll4 and re por ters of Notch sig nal ling are dis tri bu ted in a mo sa ic pat tern among ECs of ac ti vely spro u ting re ti nal ves sels. At this lo ca ti on, Notch1-de le ted ECs pre fe ren ti ally as su me tip cell cha rac te ris tics. 12, 13 When de tac hed from the ir nic hes or cul tu red in vit ro, me di a stem cells di e ra pidly or dif fe ren tia te to a cell type. This si tu a ti on disp lays the im portan ce of self ho me os ta sis of the stem cells. If we un ders tand the nic he struc tu re and cell-to-cell, cell-to-mat rix re la ti ons pro perly, the re will be a chan ce to cre a te a vir tu al "won der lan d" for the stem cells and the cells that dif fe ren ti a te from them. Thus, the num ber of the unk nowns of re gene ra ti ve me di ci ne who se im por tan ce in cre a ses gradu ally dec re a ses, re sul ting in an in cre a sed pro ba bi lity to tre at mo re ef fec ti vely. The comp lex struc tu re and in cre a se in the nic he num ber and func ti on brings up the qu es ti on whet her this kind of re la ti ons al so ari se du ring the un he althy con diti ons. The in cre a se in the know led ge abo ut this issu e lets not only the tre at ment pur po sed app li ca ti ons but al so lets to exp la in the pat ho ge nesis of the di se a ses as well. The re gu la ti ons in the nic he for a suc ces full the tre at ment is anot her impor tant is su e to be wor ked on.
AR TE RI AL, VE NO US AND LYMPHA TIC EN DOT HE LI AL CELLS IN AN GI O GE NIC PRO CESS
The exp la na ti on of the an gi o ge nic pro cess in the or ga nism thro ugh the da tas ga i ned from em bri o logi cal stu di es gi ves im por tant da tas in re ge ne ra ti ve me di ci ne app li ca ti ons. Blo od ves sels con ta in two types of cells: 1) ECs 2) mu ral cells (vas cu lar smooth musc le cells and pe ricy tes).
14 The se cells which form the ves sels show im por tant dif fe ren ces at mole cu lar le vel in dif fe rent ves sel si tes. ECs and sig nal path ways which af fect the se cells pro vi de the se diffe ren ces. For examp le trans mem bra ne li gand, Ephrin (Eph) B2, and its re cep tor trosy ne ki na se EphB4 are shown as ar te ri al and ve no us EC mar kers, res pec ti vely. 15 EphB2 which is as su med as an ar te ri al mar ker is in du ced by vas cu lar en dot he li al growth fac tor A, trig gers Notch sig nal thro ugh VEGF re cep tor-2 (VEGFR2) or ne u rop hil lin-1(NRP1) and is for med with FoxC1 and FoxC2 trans crip ti on fac tors. 13 In the for ma ti on of ve no us system Notch sig nal is bloc ked vi a the CO UP-TFI I nuc le ar orp han re cep tor and a ve no us mar ker, EphB4 forms. 13 Se ri o us vas cu lar morp ho lo gic defects oc curs by the bloc ka ge in the for ma ti on of EphB2 or EphB4. 15 An gi o ge nic for ma ti on in em brio nic or post na tal pe ri od is ma na ged vi a the ba lance bet we en pro an gi o ge nic sig nals as VEGF and CELL THERAPY FOR PERIPHERAL ARTERIAL DISEASE: CELLULAR AND MOLECULAR ASPECT Günseli ÇUBUKÇUOĞLU DENİZ et al.
in hi bi tors. Cho sen ECs are in du ced by po si ti ve signals. By the fu si on of EC,EC chan nels are for med and an gi o ge nic sig nal reg res ses by the fe ed back mec ha nism when the isc he mi a re du ces. 13 It was shown in adults that cir cu la ting EPCs in cor po ra te the ac ti ve an gi o ge ne sis si tes of the BM de ri ved or pe rip he ral blo od iso la ted an gi ob lasts and are the key fac tors for the re-en dot he li za ti on. 1 EPCs are de ter mi ned by the ex pres si on of the endot he li al mar ker pro te ins such as vas cu lar en dothe li al cad he ri ne, von Wil leb rand fac tor, KDR and en dot he li al nit ric oxi de synthe ta se. 16 Ex-vi vo cell the rapy which is for med by cul ti va ted EPCs transplan ta ti on is used for in cre a sing the ne o vas cu la riza ti on of isc he mic tis su es succ cess fully. The con cept ac cep ted re cently is that EPCs can de ri ve from BM and CD133/VEGFR2 cells ha ve the endot he li al pre mi sing ca pa city. Ho we ver, it was shown that ot her BM de ri ved cell po pu la ti ons (e.g. mye lo id cells, "si de po pu la ti o n" cells and me senchymal cells) and non-BM de ri ved cells which can dif fer to EPCs al so ha ve the sa me ca pa city. 17 EPCs du ring both em bri o nic and post na tal physi o lo gic terms con tri bu te to the tis su e vas cu la ri za ti on. In this con text, in the adults new ves sel for ma ti on is not li mi ted to the an gi o ge ne sis, inc lu des "vas cu loge ne sis and ar te ri o ge ne si s". 18 In ad di ti on to the se spe si fi ca ti ons, EPCs can be res pon sib le from en dothe li za ti on and cons ti tu ti on of non-throm bo ge nic sur fa ces in pros tet hic vas cu lar grafts. 19 Ho we ver, re ge ne ra ti ve or pat ho lo gic ne o vas cu la ri za ti on can al so oc cur by the vas cu lo ge nic in cor po ra ti on of circu la ting EPCs.
CELL SO UR CES IN AN GI O GE NE SIS STU DI ES; ONLY ONE CELL SUB GRO UP? CELL COM BI NA TI ONS? PO TEN TI AL USE OF CYTO KI NES
En do te li al cell le vels in au to gen pe rip he ral cir cula ti on is to be re se arc hed for the as ses ment of the ef fi cacy of the cell-ba sed the ra pi es in pe rip he ral arte ri al di se a ses . In se ve ral stu di es the cor re la ti on of the cir cu la ting EC le vels and pe rip he ral ar te ri al di se a se (PAD) pat ho ge ne sis is re se arc hed. In com para ti ve stu di es cir cu la ting EPC spe si fic m-RNA ex pres si ons we re ob ser ved to be low in the pre sence of the isc he mic PAD. 20 En han cing the num ber of the EPCs in cir cu la ti on be ca me an im por tant tar get for the cli ni cal stu di es. In a ran do mi zed study inclu ding thre e dif fe rent PAD gro ups it was shown that the num ber of pro ge ni tor cells in cir cu la ti on co uld be in cre a sed af ter the 4 we eks-exer ci se educa ti o nal prog ram me. 21 In anot her study of di a be tic pa ti ents, it was de tec ted that the re was a di rect rela ti ons hip bet we en EPC ra tes in cir cu la ti on and ank le-brac hi al in dex and al so the re was a sig ni ficant re duc ti on of pro ge ni tor cells in di a be tic pa tients with PAD. 22 Shi et al. 23 sho wed that EPCs in cir cu la ti on plays a ro le in vas cu lar re pa ir in dogs. In this study, pro ge ni tor cells which are mo bi li zed via gra nu locy te co lony sti mu la ting fac tor in prost hetic vas cu lar bypass graft has shown a sig ni fi cant in cre a se in en dot he li za ti on when com pa red with the con trol gro up. Af ter un ders tan ding the im portant ro le of EPCs in vas cu lar re pa ir pro cess, ex peri men tal stu di es fo cu sed to en han ce the ef fi cacy of the se pro ge ni tor cells. In the se stu di es the sta tins 24 and the es tro gen 25 we re fo und to ha ve a ro le in enhan ce ment of both EC co unt and ca pa city of re pair. In ad di ti on, it was shown that erit ro po i e tin app li ca ti ons ca u se an in cre a se in func ti o nal EPC co unt ho we ver the mec ha nism is not cle arly unders to od yet. 26 In al most all of the ex pe ri men tal mo dels follo wing the stu di es men ti o ned abo ve, the ef fi cacy of di rect cel lu lar imp lan ta ti on are as ses sed in perip he ral limb isc he mi a mo dels.
WHICH CELL?
Con sis tent with the de ve lop ments in cell ba sed the ra pi es, con trol led stu di es ma de with dif fe rent BM sub gro ups are al so sub se qu ently re por ted. "Mesench ymal cell s" which are fre qu ently men ti o ned in myo car di al re ge na ra ti on stu di es, may le ad to anot her to pic for the qu es ti on "which cel l". An impor tant is su e that is diss cus sed re cently is eva lu a ti on of the ef fec ti ve ness of the tre at ment whet her the tre at ment is ac hi e ved by me senchymal cells or mo no nuc le ar cells in pe rip he ral limb isc he mi a. Iwa se et al. 27 com pa red the ef fi cacy betwe en mo no nuc le ar cells and me sench ymal cells in an ex pe ri men tal leg isc he mi a cre a ted af ter fe mo ral ar tery li ga ti on in rats. In this ex pe ri men tal study, it was fo und that mo no nuc le ar and me sench ymal cells sti mu la ted the an gi o ge ne sis. Ne o vas cu la ri sati on vi a me sench ymal cell imp lan ta ti on was mo re sig ni fi cant than ne o vas cu la ri sa ti on vi a mo no nucle ar cell imp lan ta ti on. Me sench ymal cells dif fe renti a ted to the ECs mo re sig ni fi cantly than mo no nuc le ar cells, in ad di ti on, only the me senchymal cells dif fe ran ti a ted to vas cu lar smo oth muscle cells and me sench ymal cells we re mo re to le rab le to the isc he mic sti mu li than mo no nuc le ar cells.
PRO TE INS RE LA TED WITH AN GI O GE NE SIS
In the stu di es con cer ning the rapy ba sed an gi o gene sis, anot her im por tant is su e is de ter mi na ti on of the pro te ins re la ted with an gi o ge ne sis and transport of the pro te ins to the isc he mic tar get tis su e. Pla te let de ri ved growth fac tors (PDGF) are pre domi nantly re se arc hed pro te ins in an gi o ge ne sis stu di es. PDGFs are the first growth fac tors that are shown to ha ve a ro le in ves sel ma tu ra ti on. The ir so ur ces are the pla te lets in cir cu la ti on. 28 The re are fo ur fac tors in PDGF fa mily; PDGF-A, PDGF-B, PDGF-C, and PDGF-D. The se fac tos sho uld be in the ir di mer po si ti on (such as AA, BB, CC, DD) for be ing physi o lo gi cally ac ti ve. 29 Subt ype PDGF-BB pro vi des the ma tu ra ti on of the newly for ming vessels by in te rac ting the cir cu la ting pro ge ni tor cells of the vas cu lar pe ricy tes and smo oth musc le and and is shown to be res pon sib le for the tu mo ral lymphan gi o ge ne sis. 30 Ne vert he less, it was de tec ted that new ves sel for ma ti on was im pro ved vi a app lying PDGF-BB alo ne as well as app lying to get her with ot her an gi o ge nic pro te ins such as fib rob last growth fac tor-2 (FGF-2). 31 In ad di ti on, PDGF-CC in fu si on alo ne al so im pro ves the new ves sel for ma ti on in the isc he mi a mo dels. 32 
TIS SU E EN GI NE E RING APP LI CA TI ONS
Re se archs using tis su e en gi ne e ring met hods in perip he ral isc he mic limb mo dels are ot her is su es discus sed in the li te ra tu re re cently. It was fo und in past stu di es that col la gen mat rix sup ports the an gio ge nic pro cess.The re are ex pe ri men tal stu di es that sho wed im pro ve ment in new ves sel for ma ti on by com bi ning the pro ge ni tor cells and col la gen mat rix to get her and trans por ting them to the isc he mic tissu e. 33 
TIS SU E EN GI NE E RED VAS CU LAR GRAFTS IN CLI NI CAL USE
Con sis tent with the de ve lop ments in poly mer chemistry, vas cu lar graf ting app li ca ti ons has be en exten si vely re se ar ced by me ans of tis su e en gi ne e ring. Vas cu lar grafts for med af ter cel lu lar co a ting by the bi o deg ra dab le poly mers such as polyg lyco lic acid and polyh ydrox yal ka no a te we re imp lan ted to the lamb ca ro tid ar tery and aor ta. The se tis su e en gi nee red grafts we re still pa tent 5 months af ter the imp lan ta ti on. 34 Du ring the se stu di es it was ob ser ved that all the bi o deg ra dab le poly mers can not be absor bed. Thus, use of hya lu ro nic aci de es ters in bi odeg ra dab le poly mers was ar gu ed. It is re por ted that ap ro xi ma tely to tal ab sorb ti on oc cu red vi a the endo gen hya lu ro ni da se ac ti vity and the se poly mers sti mu la tes the an gi o ge ne sis suc cess fully. 35 To day, tis su e en gi ne e red grafts are used as ex tra car di ac con du its in con ge ni tal car di ac sur gery af ter a short pe ri od of cul ti va ti on with au to lo go us BM mo nonuc le ar cells. 36 The se grafts are app li ed to the right he art por ti ons whe re the pres su re is low. The ar teri al tis su e en gi ne e red grafts which work un der high blo od pres su re are still the sub jects of ex pe ri men tal stu di es and the re is still no cli ni cal app li ca ti ons yet.
CLI NI CAL STEM CELL APP LI CA TI ONS IN CRI TI CAL LIMB ISC HE MI A
Af ter pro mi sing re sults of the cell ba sed the ra pi es in ex pe ri men tal pe rip he ral isc he mi a mo dels, the clini cal app li ca ti ons are in use to day. Adult stem cells de ri ved from the BM con ti nu e to be un der in ten se in ves ti ga ti on by the re se arc hers whi le the pro porti o nal con tri bu ti ons of an gi o ge ne sis and vas cu lo ge ne sis to post na tal ne o vas cu la ri za ti on rema in to be cla ri fi ed. 37 In a cli ni cal set ting, Ta te is hiYu ya ma et al (TACT study) 38 ha ve re cently es tab lis hed that imp lan ta ti on of au to lo go us bo ne mar row-mo no nuc le ar cells (ABMMNC), inc lu ding EPCs, in to isc he mic limbs in cre a ses col la te ral ves sel for ma ti on. Con si de ring the comp le xity of the an gi -CELL THERAPY FOR PERIPHERAL ARTERIAL DISEASE: CELLULAR AND MOLECULAR ASPECT Günseli ÇUBUKÇUOĞLU DENİZ et al.
Damar Cer Derg 2012;21 (2) o ge nic pro cess, cel lu lar the ra pe u tic stra te gi es may over co me most of the short co mings re la ted to sing le growth fac tor app li ca ti ons. Ta te is hi-Yu ya ma et al re cently de mons tra ted im pro ve ment in trans cuta ne o us oxy gen pres su re, rest pa in, and pa in-fre e wal king ti me af ter ABMMNC in tra mus cu lar in jecti on in 25 pa ti ents with cri ti cal limb isc he mi a (CLI).
Re cently, the wi dest se ri es of pa ti ents with iso la ted throm bo an gi i tis ob li te rans is re por ted by our study gro up. 39 In our study, ABMMNC implan ta ti on was app li ed to 28 pa ti ents with Rut herford Gra de II-II I isc he mi a. The re sult of the study sug gests that ABMMNC imp lan ta ti on in to isc hemic limbs of pa ti ents with TA O is as so ci a ted with im pro ved exer ci se per for man ce, qu a lity of li fe, ank le brac hi al pres su re in dex, pa in con trol and aug men ta ti on of col la te ral for ma ti on in 24 we eks in 78% of pa ti ents. Isc he mic ul cers he a led comp letely in 15 pa ti ents (83%) and im pro ved mar kedly in thre e (17%). The long term fol low-ups of the pa tients are still con ti nu ing.
The pi lot stu di es con cer ning cell ba sed the rapi es in PAD ha ve po si ti ve re sults. Cor res pon ding to the de ve lop ments in cell ba sed the ra pi es, the re is a ne ed for stu di es ma de by mo re se lec ti ve cell subt ypes. The re are no cer ta in evi den ces for com pa rison of the ef fi ci en ci es of cell subt ypes. Furt her pros pec ti ve ran do mi sed stu di es are ne e ded to compa re ABMMNC, EPC and me sench ymal cells.
LE VELS OF EVI DEN CE IN CLI NI CAL STEM CELL APP LI CA TI ONS: IN-VI VO CELL TRAC KING
The des crip ti on of the stem cells is an im por tant mi les to ne in the de ve lop ment of the cell-ba sed therapy op ti ons. In de ter mi ning the BM de ri ved stem cells, the phe noty pe and morp ho lo gi cal spe ci fi ca tions are iden tif ying. Me sench ymal cells which were iden ti fi ed as star-li ke sha pe fib rob lasts in di rect mic ros co bic exa mi na ti on gets mo re at ten ti on in rege ne ra ti ve me di ci ne.The se cells ha ve a po ten ti al for trans for ming to all thre e germ la yer cells alt hough they are ori gi na ted from me so derm. 16 Ho wever, be ca u se of the si mi la ri ti es in cell morp ho lo gi es, it is ine vi tab le to ha ve so me in fir mity in iden tifying the stem cells. Alt ho ugh the re are still so me un de fi ned po ints, stem cells are clas si fi ed ac cor ding to the ir sur fa ce an ti gens. For examp le, sur fa ce markers such as CD105, CD166, CD44 and CD90 are uni formly ex pres sed by me sench ymal cells. 40 The iden ti fi ca ti on of the cell sur fa ce an ti gens may help to so me de ve lop ments in cell iso la ti on. The primary an ti body which is spe ci fic to the iso la ted cell sur fa ce an ti gen and the se con dary an ti bo di es which are bin ded to the pri mary an ti body spe si fic mag ne tic be ad can be eva lu a ted for the mag ne tic se pe ra ti on pro cess (mag ne tic ac ti va ted cell sor ting). Thus, po si ti ve and ne ga ti ve cell se lec ti on can be achi e ved. With this met hod mo re spe si fic cell iso lata ti on such as yo un ger pro ge ni tor cells which ha ve sup re me dif fe ren ti a ti on ca pa city to the ot her tis sues (os te o ge nic, adi po ge nic etc.) is pro vi ded. 41 Mo le cu lar met hods are fre qu ently used in studi es for iden tif ying the dif fe ran ti a ti on ca pa city of the pro ge ni tor cells. Pro ge ni tor cells which are expo sed to the gre en fle u ros ce ne pro te in (GFP) transduc ti on are app li ed to both in-vi vo and in-vit ro dif fe ran ti a ti on pro cess. In this con text, car di ac and vas cu lar mar ker ex pres si on of the GFP or nuc le ar Dil pa int ac ti vity sho wing cells are shown vi a the im mu no his toc he mistry met hods. 1, 42 The se fin dings are the high evi den ce le vel fin dings which show the ex-vi vo dif fe ran ti a ti on abi lity of the pro ge ni tor cells.
VI SU A LI SA TI ON OF NE O VAS CU LA RI SA TI ON
Cor res pon ding to the in cre a se in both ex pe ri mental and cli ni cal stem cell app li ca ti ons in pe rip he ral ar tery di se a ses, the re is a ne ed for vi su a li za ti on of the ac hi e ved ne o vas cu la ri za ti on vi a the im pro ved tech ni qu es. Zhu ang et al. 43 fo und that col la te ral ves sel for ma ti ons en han ced by cell ba sed the ra pi es are fre qu ently in a di a me ter of 10-45 m. It was repor ted that ves sel for ma ti ons over 200 m of di ame ter can be vi su a li zed by the con ven ti o nal an gi og rap hic disp lay met hods. In the sa me study it was de ter mi ned that col la te ral ves sel for ma ti ons un der 200 µm of di a me ter we re vi su a li zed vi a the 3D mul ti de tec tor com pu ted to mog raphy an gi ography. In fu tu re,it will be pos sib le to disp lay the effi cacy of the the rapy vi a the cell ba sed and vi rus me di a ted an gi o ge nic pro te in app li ca ti ons for ne ovas cu la ri za ti on. 
SU PER MAG NE TIC IRON OXI DE (SPI O) MAR KED STEM CELLS
The su per mag ne tic iron oxi de (SPI O) na no par ticle-mar ked stem cells may be de tec ted in vi vo. Kraitc hman et al. 44 imp lan ted SPI O mar ked-cells to the ex pe ri men tal myo card in farc ti on si tes. SPI O -marked me sench ymal cells we re de tec ted by mag ne tic re so nans ima ging (MRI) at imp lan ta ti on si tes af ter 14th day of imp lan ta ti on. SPI O mar ked cells can be de tec ted in the imp lan ta ti on si tes vi a MRI ho we ver, this met hod do esn't gi ve any in for ma ti on abo ut cell vi a bi lity. The re is a risk for fal se po si ti ve de tec ti on of mac rop ha ge-pha gocy ted, in vi ab le stem cells. The re is not eno ugh in for ma ti on abo ut the to xic effects of the SPI O na no par tic les to the tis su es. In addi ti on, the re is no study ma de abo ut the po ten ti al na ga ti ve ef fects of SPI O in vas cu lo ge nic dif fe ran tia ti on of the stem cells. The re sho uld be a num ber of at le ast 10 8 co lo ni za ti ons of the mar ked cells for being de tec ted vi a MRI. Be low this cell co unt den sity any MRI vi su a li za ti on can not be ac hi e ved. Be ca use of the se re a sons, alt ho ugh this met hod has ga i ned gre at at ten ti on at the be gin ning, la ter it has lost its im por tan ce. Pre re qu i si ti es for cli ni cal app li ca bi lity of con trast agents for cell la be ling are bi o com pa tibi lity, sa fety, and non to xi city for tis su es.
De ta i led stu di es are ne e ded for disp la ying the cli ni cal ef fi cacy of the cell ba sed the ra pi es in ische mi a mo dels. One part of the se stu di es are abo ut the nuc le ar vi si u a li za ti on met hods.
USE OF RA DI O NUC LI DES
Di rect la be ling of cells with ra di o nuc li des pro vi des the ad van ta ge of a lo wer back gro und sig nal as compa red with MRI. Ho we ver, hig her sen si ti vity is achi e ved at the cost of lo wer spa ti al re so lu ti on. Va ri o us cli ni cally app li cab le ra di o nuc li des ha ve been used, ba sed on pre vi o usly es tab lis hed pro to cols for le u kocy te or throm bocy te scin tig raphy. Di rect la be ling with ra di o nuc li des ap pe ars highly in forma ti ve for cli ni cal stu di es ad dres sing ho ming and bi o dis tri bu ti on af ter cell in jec ti on. Hu a et al. 45 ha ve de tec ted that the an gi o ge ne sis si tes we re vi su a li zed as "hot spo t" in per fu si on scin tig raphy vi a pep ti de bin ded TC99m tar ge ting the αvß3 in teg rin si tes of the en dot he li al cells in ex pe ri men tal pe rip he ral limb isc he mi a. The "hot spot s" which we re the markers of an gi o ge ne sis in per fu si on scin tig raphy we re con fir med by im mu no his toc he mi cal met hods. In ot her words, it was shown that the si tes which were the " hot spot s" of scin tig raphy we re con sis tent with the ne o vas cu la ri za ti on si tes im mu no his toc hemi cally. We think that the re will be cli ni cal ref lecti ons of the pep ti de mar ked per fu si on scin tig raphy spe si fic to the en dot he li al cells for vi su a li zing the the ra u pe tic cell ba sed the ra pi es ahe ad.
The re are stu di es per for med abo ut de tec ti on of the ra di o i so to pe mar ked stem cells af ter com mu nica ting to the tar get si te vi a the sing le pho ton emissi on com pu ted to mog raphy (SPECT) and po sit ron emis si on to mog raphy (PET) in the tis su es. Ra di o acti ve iso to pes such as [In-111]oxy qu i no li ne (oxi ne) and [T-99m] he xa methy lproph yle ne ami ne oxi me ha ve be en cli ni cally used in the nuc le ar me di ci ne for la be ling au to lo go us whi te blo od cells, which are sub se qu ently in fu sed back to the pa ti ents for lo cali za ti on of inf lam ma tory si tes. In ge ne ral, ra di o i soto pes with a re la ti vely long de cay half-li fe are used to track cells du ring a pe ri od of se ve ral ho urs or even days, for ins tan ce In-111 (T1/2= 2.8 days) for SPECT and (T1/2= 12.7 h) for PET. 46 Ra di o ac ti ve mar ked cells can be de tec ted vi a this met hod in vivo. Ho we ver, it is not a pro perly as the re is po tenti al to xic ef fects of the ra di o i so to pe agents on stem cells whats mo re, the re can't be any vi su a li za ti on after 7 days be ca u se of the ra di o ac ti vity loss and in viab le cells can gi ve ra di o ac ti vity. And al so as the sig nals ta ken from mar ked cells can not gi ve any infor ma ti on abo ut dif fe ren ti a ti on pro cess, the met hod was shown in li mi ted num ber of stu di es.
MO LE CU LAR BI O LO GIC MET HODS: "RE POR TER GE NE AP PRO AC HES FOR CELL TRAC KIN G"
Re se arc hes for de ter mi ning the tis su e-tar ge ted stem cells as vi abl sta tus are still con ti nu ing. For di rect vi su a li za ti on of the ef fi cacy of the the rapy, mo lecu lar bi o lo gic met hods are used. "Tra cer Trap ping Met hod s" are re cently used to vi su a li ze the vi abl cells in cell app li ca ted tar get si tes. This met hod mainly con sists of ge ne trans duc ti on that pro du ce pro-CELL THERAPY FOR PERIPHERAL ARTERIAL DISEASE: CELLULAR AND MOLECULAR ASPECT Günseli ÇUBUKÇUOĞLU DENİZ et al.
Damar Cer Derg 2012;21 (2) te ins which can be de tec ted by SPECT or PET vi a vi ral re por ters. For this pur po se, ti mi din ki na se (tk) re por ter ge ne 47 and trip le fu si on (TF) ge ne 48 transduc ti ons are used fre qu ently. As a re por ter ge ne, tk, en teg ra tes to the stem cell ge no mic DNA af ter intro du cing to the cel lu lar nuc le i. Af ter the transcrip ti on and trans la ti on steps, pri mi di ne ana lo u ges and acy clo gu a no si ne de ri va ti ves, which can be detec ted by SPECT and PET, de po si te in the cell. When the TF trans duc ti on is used as the met hod, the pro ducts such as mo no me ric red fle u ro sans prote in (mrfp), fi refly lu ci fe ra se(fluc), trun ca ted ti midi ne ki na se (ttk) which can be de tec ted vi a vi si u a li zing met hods are ga i ned. Vi abl stem cell follow-up co uld not be ac hi e ved by in vi vo cell fol low met hods un till the se de fi ned met hods we re used recently. A ma jor di sad van ta ge of re por ter ge ne appro ac hes for cell trac king is the re qu i re ment for mo le cu lar ma ni pu la ti ons of the cells un der study. Ot her po ten ti al con cerns re gar ding long-term ef ficacy of the met hod inc lu de re por ter ge ne si len cing, in which re por ter ge ne ex pres si on dec re a ses over ti me with prog res si ve cell dif fe ren ti a ti on. Anot her im por tant is su e is that te ra to ma for ma ti ons we re ob ser ved in ex pe ri men tal stu di es, es pe ci ally her pes simp lex vi rus was used as a ge ne trans por ter. 48 
HOW SHO ULD AN IDE AL NON-INVA SI VE IN VI VO IMA GING TECH NI QU E BE?
Ide al, no nin va si ve in vi vo ima ging tech no lo gi es sho uld ha ve ca pa bi li ti es of (1) bi o a va i li bi lity, safety, and non-to xi city; (2) no ge ne tic mo di fi ca ti on or per tur ba ti on to the stem cell (3) re al-ti me vi sua li za ti on of in jec ted cells eit her in the tar get are a or thro ug ho ut the body; (4) sing le-cell de tec ti on at any ana to mic lo ca ti on; (5) mi ni mal or no trans fer of con trast agent to non-stem cells; (6) no nin va sive ima ging in the li ving sub ject over months to years; (7) no re qu i re ment for in jec tab le con trast agent; (8) stem cell qu an ti fi ca ti on; (9) long-term, se ri al tra ce a bi lity; (10) sing le cell sen si ti vity in any lo ca ti on; and (11) re du ced fal se po si ti ve ima ging. 49 
CON TRAST AGENTS
A num ber of con trast agents and de tec tors for no nin va si ve, re pe a tab le vi su a li za ti on of the ra pe u tic cells in vi vo ha ve be en pur su ed. Re gard less of the le vel of sen si ti vity fi nally ac hi e ved, qu an ti fi ca ti on of cell num ber may be es pe ci ally dif fi cult when we con sider the ef fects of con trast agent di lu ti on du ring cell di vi si on, the pro pen sity of so me con trast agents to trans fer to non-stem cells, and cer ta in tech ni cal limi ta ti ons. Such ima ging ap pro ac hes may not only re fi ne the un ders tan ding of the ra pe u tic mec ha nisms in prec li ni cal stu di es but may al so ha ve di rect cli nical app li ca ti ons. Most of the ava i lab le cel lu lar mo lecu lar ima ging tech ni qu es are al so app li cab le in hu mans, and the re fo re may fa ci li ta te ra pid trans lati on of cell-ba sed the ra pi es in to cli ni cal prac ti ce. The ide al ima ging tech no logy sho uld per mit trac king of in jec ted stem cells for months to ye ars as clini cal tri als will re qu i re long-term fol low-up of tis su e func ti on or host sur vi val. Fi nally, in jec tab le con trast agents, such as enz yme subs tra tes, add comp le xity and cost to stem cel l-t rac king pro ce du res.
Cell ba sed the ra pi es are im pro ving prog res sively in car di vas cu lar di se a ses. In spi te of the impor tant re sults in la bo ra tory stu di es, bet ter re sults in in vi vo met hods which will di rectly show the cli ni cal ef fi cacy of the cell ba sed the ra pi es are yet to be re ac hed. Disp la ying of the in vi vo, vi abl, and long term ho ming/dif fe ran ti a ti on pro ces ses of the cells is one of the im por tant po ints in ob jec ti ve disp lay of the the rapy ef fi cacy. Com bi ned usa ge of the mo le cu lar and vi si u a li zing met hods to get her will pro bably help the so lu ti on of this prob lem. 
